CLINICAL RESEARCH
Cardiac resynchronization therapyhomogenizes myocardial glucosemetabolism and perfusion in dilatedcardiomyopathy and left bundle branch block
Bernd Nowak, MD*,*,
Anil M. Sinha, MD, PhD ,
Wolfgang M. Schaefer, MD, PhD*,
Karl-Christian Koch, MD ,
Hans-Juergen Kaiser, PhD*,
Peter Hanrath, MD, FACC ,
Udalrich Buell, MD* and
Christoph Stellbrink, MD
* Department ofNuclear Medicine, University Hospital, Aachen University of Technology, Aachen, Germany
Internal Medicine I (Cardiology), University Hospital, Aachen University of Technology, Aachen, Germany
Manuscript received September 17, 2002;
revised manuscript received December 23, 2002,
accepted December 27, 2002.
* Reprint requests and correspondence: Dr. Bernd Nowak, Department of Nuclear Medicine, University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany. bnowak{at}ukaachen.de
OBJECTIVES: We investigated whether cardiac resynchronization therapy (CRT) affects myocardial glucose metabolism and perfusion in dilated cardiomyopathy (DCM) and left bundle branch block (LBBB).
BACKGROUND: Patients with DCM and LBBB present with asynchronous left ventricular (LV) activation, leading to reduced septal glucose metabolism. Cardiac resynchronization therapy recoordinates LV activation, but its effects on myocardial glucose metabolism and perfusion remain unknown.
METHODS: In 15 patients (10 females; 61 ± 13 years) with DCM and LBBB (QRS width 165 ± 15 ms), gated 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and technetium-99m (99mTc)-sestamibi single-photon emission computed tomography were performed before and after two weeks of CRT. Uptake of FDG and 99mTc-sestamibi was determined in four LV wall areas. Ejection fraction and volumes were calculated from gated PET.
RESULTS: Baseline FDG uptake was heterogeneous (p < 0.0001), with lowest uptake in the septal region (56 ± 12%) and highest uptake in the lateral region (89 ± 6%). During CRT, septal and anterior increases (p < 0.01) and lateral decreases (p < 0.01) resulted in homogeneously distributed glucose metabolism. Baseline heterogeneity (p < 0.0001) in 99mTc-sestamibi uptake was modest (lowest septal 65 ± 10%; maximum lateral 84 ± 5%) and also reduced with CRT, although some heterogeneity (p < 0.05) remained. The septal-to-lateral ratio increased with CRT for FDG (0.62 ± 0.12 to 0.91 ± 0.26, p < 0.001) and 99mTc-sestamibi uptake (0.77 ± 0.13 to 0.85 ± 0.16, p < 0.01). The LV end-diastolic and end-systolic volumes decreased from 293 ± 160 to 272 ± 158 ml (p < 0.05) and from 244 ± 164 to 220 ± 160 ml (p < 0.01), respectively. Ejection fraction increased from 22 ± 12% to 25 ± 13% (p < 0.01).
CONCLUSIONS: Glucose metabolism is reduced more than perfusion in the septal compared with LV lateral wall in patients with DCM and LBBB. Cardiac resynchronization therapy restores homogeneous myocardial glucose metabolism with less influence on perfusion.
|
Abbreviations and Acronyms
| | CRT | = cardiac resynchronization therapy | | DCM | = dilated cardiomyopathy | | FDG | = 18F-fluorodeoxyglucose | | HF | = heart failure | | LBBB | = left bundle branch block | | LV | = left ventricular | | LVEDV andLVESV | = left ventricular end-diastolic and end-systolic volume, respectively | | LVEF | = left ventricular ejection fraction | | PET | = positron emission tomography | | SPECT | = single-photon emission computed tomography | | 99mTc | = technetium-99m |
|
This article has been cited by other articles:

|
 |

|
 |
 
P. Koepfli, C. A. Wyss, O. Gaemperli, P. T. Siegrist, M. Klainguti, T. Schepis, M. Namdar, M. Bechir, T. Hoefflinghaus, F. Duru, et al.
Left bundle branch block causes relative but not absolute septal underperfusion during exercise
Eur. Heart J.,
September 5, 2009;
(2009)
ehp372v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Barth, T. Aiba, V. Halperin, D. DiSilvestre, K. Chakir, C. Colantuoni, R. S. Tunin, V. L. Dimaano, W. Yu, T. P. Abraham, et al.
Cardiac Resynchronization Therapy Corrects Dyssynchrony-Induced Regional Gene Expression Changes on a Genomic Level
Circ Cardiovasc Genet,
August 1, 2009;
2(4):
371 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Askew, T. Miller, R. Gibbons, and P. Chareonthaitawee
Effects of left bundle branch block and right ventricular pacing on assessing myocardial viability by positron emission tomography.
J. Am. Coll. Cardiol. Img.,
May 1, 2009;
2(5):
661 - 663.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Parsai, A. Baltabaeva, L. Anderson, M. Chaparro, B. Bijnens, and G. R. Sutherland
Low-dose dobutamine stress echo to quantify the degree of remodelling after cardiac resynchronization therapy
Eur. Heart J.,
April 2, 2009;
30(8):
950 - 958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Sweeney and F. W. Prinzen
Ventricular Pump Function and Pacing: Physiological and Clinical Integration
Circ Arrhythm Electrophysiol,
June 1, 2008;
1(2):
127 - 139.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Valzania, F. Gadler, R. Winter, F. Braunschweig, L.-A. Brodin, P. Gudmundsson, G. Boriani, and M. J. Eriksson
Effects of cardiac resynchronization therapy on coronary blood flow: Evaluation by transthoracic Doppler echocardiography
Eur J Heart Fail,
May 1, 2008;
10(5):
514 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Chakir, S. K. Daya, R. S. Tunin, R. H. Helm, M. J. Byrne, V. L. Dimaano, A. C. Lardo, T. P. Abraham, G. F. Tomaselli, and D. A. Kass
Reversal of Global Apoptosis and Regional Stress Kinase Activation by Cardiac Resynchronization
Circulation,
March 18, 2008;
117(11):
1369 - 1377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Henneman, E. E. van der Wall, C. Ypenburg, G. B. Bleeker, N. R. van de Veire, N. A. Marsan, J. Chen, E. V. Garcia, J. J.M. Westenberg, M. J. Schalij, et al.
Nuclear Imaging in Cardiac Resynchronization Therapy
J. Nucl. Med.,
December 1, 2007;
48(12):
2001 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Europace,
October 1, 2007;
9(10):
959 - 998.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Eur. Heart J.,
September 2, 2007;
28(18):
2256 - 2295.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Vernooy, R. N.M. Cornelussen, X. A.A.M. Verbeek, W. Y.R. Vanagt, A. van Hunnik, M. Kuiper, T. Arts, H. J.G.M. Crijns, and F. W. Prinzen
Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts
Eur. Heart J.,
September 1, 2007;
28(17):
2148 - 2155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ashrafian, M. P. Frenneaux, and L. H. Opie
Metabolic Mechanisms in Heart Failure
Circulation,
July 24, 2007;
116(4):
434 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Thompson, G. Saab, D. Birnie, B. J.W. Chow, H. Ukkonen, K. Ananthasubramaniam, R. A. deKemp, L. Garrard, T. D. Ruddy, J. N. DaSilva, et al.
Is Septal Glucose Metabolism Altered in Patients with Left Bundle Branch Block and Ischemic Cardiomyopathy?
J. Nucl. Med.,
November 1, 2006;
47(11):
1763 - 1768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Lindner, J. Sorensen, J. Vogt, E. Fricke, D. Baller, D. Horstkotte, and W. Burchert
Cardiac Efficiency and Oxygen Consumption Measured with 11C-Acetate PET After Long-Term Cardiac Resynchronization Therapy
J. Nucl. Med.,
March 1, 2006;
47(3):
378 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Bax, T. Abraham, S. S. Barold, O. A. Breithardt, J. W.H. Fung, S. Garrigue, J. Gorcsan III, D. L. Hayes, D. A. Kass, J. Knuuti, et al.
Cardiac Resynchronization Therapy: Part 2--Issues During and After Device Implantation and Unresolved Questions
J. Am. Coll. Cardiol.,
December 20, 2005;
46(12):
2168 - 2182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stellbrink
Heart rate, regularity, and synchronicity in heart failure: a tale of three brothers
Eur. Heart J.,
April 1, 2005;
26(7):
637 - 638.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Lindner, J. Vogt, D. Baller, A. Kammeier, P. Wielepp, J. Holzinger, B. Lamp, D. Horstkotte, and W. Burchert
Global and regional myocardial oxygen consumption and blood flow in severe cardiomyopathy with left bundle branch block
Eur J Heart Fail,
March 2, 2005;
7(2):
225 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Lindner, J. Vogt, A. Kammeier, P. Wielepp, J. Holzinger, D. Baller, B. Lamp, B. Hansky, R. Korfer, D. Horstkotte, et al.
Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy
Eur. Heart J.,
January 1, 2005;
26(1):
70 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Vernooy, X. A.A.M. Verbeek, M. Peschar, H. J.G.M. Crijns, T. Arts, R. N.M. Cornelussen, and F. W. Prinzen
Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion
Eur. Heart J.,
January 1, 2005;
26(1):
91 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Preumont, J.-L. Jansens, G. Berkenboom, P. van de Borne, E. Stoupel, and S. Goldman
Effects of right ventricular pacing on regional myocardial glucose metabolism
Europace,
January 1, 2005;
7(6):
584 - 591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Gibbons and P. A. Araoz
The year in cardiac imaging
J. Am. Coll. Cardiol.,
November 16, 2004;
44(10):
1937 - 1944.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Knaapen, L. M.C. van Campen, C. C. de Cock, M. J.W. Gotte, C. A. Visser, A. A. Lammertsma, and F. C. Visser
Effects of Cardiac Resynchronization Therapy on Myocardial Perfusion Reserve
Circulation,
August 10, 2004;
110(6):
646 - 651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Mehra and B. H. Greenberg
Cardiac resynchronization therapy: caveat medicus!
J. Am. Coll. Cardiol.,
April 7, 2004;
43(7):
1145 - 1148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sciagra, M. Giaccardi, M. C. Porciani, A. Colella, A. Michelucci, P. Pieragnoli, G. Gensini, A. Pupi, and L. Padeletti
Myocardial Perfusion Imaging Using Gated SPECT in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy
J. Nucl. Med.,
February 1, 2004;
45(2):
164 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|